Literature DB >> 33620749

Impact of cumulative incarceration and the post-release period on syringe-sharing among people who inject drugs in Tijuana, Mexico: a longitudinal analysis.

Carlos D Rivera Saldana1,2, Leo Beletsky1,3, Annick Borquez1, Susan M Kiene2, Steffanie A Strathdee1, María Luisa Zúñiga4, Natasha K Martin1,5, Javier Cepeda1.   

Abstract

BACKGROUND AND AIMS: Syringe-sharing among people who inject drugs, which can occur during incarceration and post-release, has been linked with increased risk of blood-borne infections. We aimed to investigate the cumulative effect of repeated incarceration and the post-release period on receptive syringe-sharing.
DESIGN: Ongoing community-based cohort, recruited through targeted sampling between 2011 and 2012 with 6-month follow-ups.
SETTING: Tijuana, Mexico. PARTICIPANTS: Sample of 185 participants (median age 35 years; 67% female) with no history of incarceration at study entry, followed to 2017. MEASUREMENTS: Cumulative incarceration and post-release period were constructed from incarceration events reported in the past 6 months for each study visit. Receptive syringe-sharing in the past 6 months was assessed as a binary variable. We used logistic regression with generalized estimating equations to examine the association between cumulative incarceration events and the post-release period with receptive syringe-sharing over time. Missing data were handled through multiple imputation.
FINDINGS: At baseline, 65% of participants engaged in receptive syringe-sharing in the prior 6 months. At follow-up, 150 (81%) participants experienced a total of 358 incarceration events [median = 2, interquartile range (IQR) = 1-3]. The risk of receptive syringe-sharing increased with the number of repeated incarcerations. Compared with never incarcerated, those with one incarceration had 1.28 [95% confidence interval (CI) = 0.97-1.68] higher adjusted odds of syringe-sharing; two to three incarcerations, 1.42 (95% CI = 1.02-1.99) and more than three incarcerations, 2.10 (95% CI = 1.15-3.85). Participants released within the past 6 months had 1.53 (95% CI = 1.14-2.05) higher odds of sharing syringes compared with those never incarcerated. This post-release risk continued up to 1.5 years post-incarceration (adjusted odds ratio = 1.41, 95% CI = 1.04-1.91), but then waned.
CONCLUSIONS: A longitudinal community cohort study among people who inject drugs suggested that the effects of incarceration on increased injecting risk, measured through syringe-sharing, are cumulative and persist during the post-release period.
© 2021 Society for the Study of Addiction.

Entities:  

Keywords:  Cumulative incarceration; PWID; Tijuana; longitudinal; multiple imputation; post-release; re-entry

Mesh:

Substances:

Year:  2021        PMID: 33620749      PMCID: PMC8380753          DOI: 10.1111/add.15445

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   7.256


  43 in total

1.  Community reentry challenges after release from prison among people who inject drugs in St. Petersburg, Russia.

Authors:  Javier A Cepeda; Marina V Vetrova; Alexandra I Lyubimova; Olga S Levina; Robert Heimer; Linda M Niccolai
Journal:  Int J Prison Health       Date:  2015

2.  Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.

Authors:  Håvard Midgard; Behzad Hajarizadeh; Evan B Cunningham; Brian Conway; Markus Backmund; Philip Bruggmann; Julie Bruneau; Stefan Bourgeois; Adrian Dunlop; Graham R Foster; Margaret Hellard; Geert Robaeys; Maria C Thurnheer; Martin Weltman; Janaki Amin; Philippa S Marks; Sophie Quiene; Gregory J Dore; Olav Dalgard; Jason Grebely
Journal:  Int J Drug Policy       Date:  2017-06-19

3.  HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.s. border city of Tijuana.

Authors:  Carlos Magis-Rodríguez; Kimberly C Brouwer; Sonia Morales; Cecilia Gayet; Remedios Lozada; Raul Ortiz-Mondragón; Erin P Ricketts; Steffanie A Strathdee
Journal:  J Psychoactive Drugs       Date:  2005-09

4.  The law on the streets: Evaluating the impact of Mexico's drug decriminalization reform on drug possession arrests in Tijuana, Mexico.

Authors:  J Arredondo; T Gaines; S Manian; C Vilalta; A Bañuelos; S A Strathdee; L Beletsky
Journal:  Int J Drug Policy       Date:  2018-01-04

5.  HIV, drugs and the legal environment.

Authors:  Steffanie A Strathdee; Leo Beletsky; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2014-09-16

6.  Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico.

Authors:  Meredith C Meacham; Scott C Roesch; Steffanie A Strathdee; Suzanne Lindsay; Patricia Gonzalez-Zuniga; Tommi L Gaines
Journal:  Drug Alcohol Rev       Date:  2017-03-24

7.  Policing practices and HIV Risk Among People Who Inject Drugs - a Systematic Literature Review.

Authors:  Pieter Baker; Leo Beletsky; Liliana Avalos; Christopher Venegas; Carlos Rivera; Steffanie A Strathdee; Javier Cepeda
Journal:  Epidemiol Rev       Date:  2020-11-13       Impact factor: 6.222

Review 8.  Public health and the epidemic of incarceration.

Authors:  Dora M Dumont; Brad Brockmann; Samuel Dickman; Nicole Alexander; Josiah D Rich
Journal:  Annu Rev Public Health       Date:  2012-01-03       Impact factor: 21.981

9.  Factors associated with drug-related harms related to policing in Tijuana, Mexico.

Authors:  Tyson Volkmann; Remedios Lozada; Christy M Anderson; Thomas L Patterson; Alicia Vera; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2011-04-08

10.  Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.

Authors:  Angela M Robertson; Richard S Garfein; Karla D Wagner; Sanjay R Mehta; Carlos Magis-Rodriguez; Jazmine Cuevas-Mota; Patricia Gonzalez Moreno-Zuniga; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2014-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.